These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 209530)

  • 1. Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.
    Vlaicu R; Popescu E; Popescu TA; Cucuianu M
    Endocrinologie; 1978; 16(2):147-51. PubMed ID: 209530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
    Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
    Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in lipoprotein research: biochemical and clinical aspects.
    Schettler G; Seidel D; Greten H
    Med J Aust; 1973 May; 1(19):942-6. PubMed ID: 4351788
    [No Abstract]   [Full Text] [Related]  

  • 5. 'In vitro' binding of propofol to serum lipoproteins in thyroid dysfunction.
    de la Fuente L; Lukas JC; Vázquez JA; Jauregizar N; Calvo R; Suárez E
    Eur J Clin Pharmacol; 2002 Dec; 58(9):615-9. PubMed ID: 12483454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoproteins in middle-aged men with psoriasis.
    Vahlquist C; Michaëlsson G; Vessby B
    Acta Derm Venereol; 1987; 67(1):12-5. PubMed ID: 2436408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum pseudocholinesterase activity during experimental fattening.
    Popescu TA; Fekete T; Popescu E; Böjthy I; Laszlo M
    Med Interne; 1976; 14(1):71-3. PubMed ID: 946698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
    Artery; 1982; 10(4):266-85. PubMed ID: 7181672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia.
    Cucuianu M; Popescu TA; Opincaru A; Hărăgus S
    Clin Chim Acta; 1975 Feb; 59(1):19-27. PubMed ID: 164306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age dependence of beta-lipoproteins in comparison with cholesterol and triglycerides in the serum of SPF rats].
    Metz A; Reinert K; Madörin M; Götz U
    Arzneimittelforschung; 1981; 31(5):809-13. PubMed ID: 7196741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in lipoprotein research. Biochemical and clinical aspects.
    Schettler G; Seidel D; Greten H
    Arch Inst Cardiol Mex; 1973; 43(3):474-87. PubMed ID: 4374142
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood lipoproteins in modeling of atherosclerosis and administration of protamine].
    Bozhko GKh; Voloshin PV; Boĭko TP; Kostiukovskaia LS
    Biull Eksp Biol Med; 1991 Jul; 112(7):44-6. PubMed ID: 1793851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipid and lipoprotein profile in children with malabsorption: an approach to the recognition of atherosclerosis risk factors.
    Szczepański Z; Malecka-Torbus A; Obuchowicz A; Swietochowska I; Zaba R; Wróbel-Lasok B
    Acta Paediatr Acad Sci Hung; 1981; 22(4):309-12. PubMed ID: 6952747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholinesterase: function in lipoprotein metabolism.
    Kutty KM; Redheendran R; Murphy D
    Experientia; 1977 Apr; 33(4):420-2. PubMed ID: 193712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease.
    Kutty KM; Jain R; Huang S; Kean K
    Clin Chim Acta; 1981; 115(1):55-61. PubMed ID: 7261407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.